SNPs in PTPN22 gene are linked to an increased risk of developing autoimmune diseases such as Alopecia Areata, RA, Graves’ Disease, Primary Sjogren Syndrome, Generalized Vitiligo, Myasthenia Gravis, Addison Disease, Systemic Sclerosis, and SLE by enhancing T-cell proliferation and activation of T-cells (20). This evidence concerns the gene PTPN22 and myasthenia gravis.